Skip to content
USD $
0.00
0
Cart
Search
(780) 448-0585
IOT.V 0.08 0.00 0.00%
|
OTCQB:IOTCF
Services
By Application
Anti-Adherence
Anti-Encrustation Testing
Antimicrobials
Environmental Bioburden Monitoring
Facility Water Testing
GMP Analytical Chemistry Testing Services
Medical Device Testing
MIC, MBC, MFC, Toxicology Testing
Microbial Identification Services
Microbiology Testing Services
Pharmaceutical & Drug Development
Stability Testing Services
Sterility Testing
By Method
Antimicrobial Effectiveness Testing USP <51>
ASTM Testing Services
BEST Assay™ Method
Environmental Bioburden Monitoring
GMP Analytical Chemistry Testing Services
MBEC Assay® Testing
Method Development and Validation Services
MIC, MBC, MFC, Toxicology Testing
Probiotic Testing for Natural Health Products USP <64>
By Industry
Compounding Pharmacies
Medical Device Testing
Pharmaceutical & Drug Development
Products
MBEC
InnovoTEST
InnovoSIL™ Silver
Resources
Investor Relations
Company
Our Team / History
Careers
Quality
Contact
Contact Us
Back to Financial Statements
Interim Financial Statements & MD&A for three and six-month periods ended June 30, 2026 and 2025
August 19, 2026
Download Financial Statements
Accompanying MD&A
